Shutterstock
Josh Ludwig, Global Commercial Director, ScaleReady
Simplifying CGT: A Necessary Precursor to Integrating AI and Automation
Josh Ludwig, Global Commercial Director, ScaleReady explores the necessity of simplifying cell and gene therapy in order to successfully integrate artificial intelligence and automation technologies in our latest EPM insight.
Published:
|
4 min read
Last updated:
Sign up to our newsletter
The week's biggest stories from this industry, direct to your inbox.